Interests

  • Lambda phage

  • Gene therapy

  • Pharmaceutical science

Hibah Alattas

Ph.D. Candidate & Research Scientist

Hibah is currently enrolled as a Ph.D. student at the University of Waterloo, within the School of Pharmacy. Previously, she completed her Pharm.D. at King Abdulaziz University-School of Pharmacy in Saudi Arabia. In 2015, she successfully defended her Master’s Thesis, “Isolation and Characterization of Host Mutants that Suppress the Bacteriophage Lambda Rex Phenotype” at the University of Waterloo, School of Pharmacy. She is now working to elucidate the mechanism behind a unique and historic phenotype, the T4rII exclusion (or Rex) phenotype.

Education

  • M.Sc. Pharmacy, University of Waterloo (2015)

  • Pharm.D., King AbdulAziz University-School of Pharmacy, Saudi Arabia

Contact

  • hibah.alattas@theraphage.bio


PUBLICATIONS:

Presentations:

  • Alattas H., Identification of E. coli Host Genes Influencing T4rII Exclusion Phenotype. Presented at: University of Waterloo Pharmacy Research Day. 2023 March 17; Waterloo ON.

  • Alattas H., Isolation and Characterization of Host Mutations that Suppress the Bacteriophage Lambda (λ) Rex Phenotype. Poster Presented at the Molecular Genetics of Bacteria and Bacteriophage conference.Poster presented at the Canadian Society of Microbiologists conference. 2017 June 20-23; Waterloo ON

  • Alattas H., Isolation and Characterization of Host Mutations that Suppress the Bacteriophage Lambda (λ) Rex Phenotype. Poster Presented at the Molecular Genetics of Bacteria and Bacteriophage conference. 2016 August 8-12; Madison USA

Awards:

  • Taibah University Scholarship, 2016-2022

  • Nominated for Dean’s Dissertation Award, 2015